Tag: Probodies
Leading Experts in Cancer Immunotherapy and Antibody-drug Conjugates Join CytomX Scientific...
CytomX Therapeutics, Inc (343 Oyster Point Boulevard #100, South San Francisco, CA 94080), a biotechnology company developing Probody™ therapeutics for the treatment of cancer,...
A Chemistry Driven Approach to Uniform Antibody-drug Conjugates: New Data on...
Earlier today, during a plenary session of the 2015 World ADC Summit, being held October 26-29, 2014 in San Diego, California, Randall Halcomb, PhD, Vice President Chemistry at Igenica Biotherapeutics,
presented new data utilizing the company's SNAP site-specific ADC linker technology.
